Partnerships for Countermeasures against Select Pathogens (R01)

Funding Opportunity RFA-AI-16-034 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate countermeasures (therapeutics, vaccines and related technologies, or diagnostics) against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding